Otsuka Holdings Co (STU:OS1) Common Stock: €445 Mil (As of Mar. 2026)


STU:OS1 Otsuka Holdings Co Ltd STU:OS1
87 GF Score
Price €60.50
GF Value €44.74
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Otsuka Holdings Co Common Stock?

Otsuka Holdings Co STU:OS1 -2.42% 87 Common Stock is €445 Mil as of Mar. 2026. GuruFocus rates STU:OS1 with a GF Score™ of 87/100 and a GF Value™ of €44.74 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Otsuka Holdings Co's quarterly common stock declined from Sep. 2025 (€471 Mil) to Dec. 2025 (€447 Mil) and declined from Dec. 2025 (€447 Mil) to Mar. 2026 (€445 Mil).

Otsuka Holdings Co's annual common stock declined from Dec. 2023 (€520 Mil) to Dec. 2024 (€507 Mil) and declined from Dec. 2024 (€507 Mil) to Dec. 2025 (€447 Mil).

Otsuka Holdings Co Common Stock Historical Data

* Premium members only.

The historical data trend for Otsuka Holdings Co's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Otsuka Holdings Co Common Stock Chart

Otsuka Holdings Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 635.10 571.59 520.27 507.20 447.44

Otsuka Holdings Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 506.94 490.20 470.71 447.44 445.30
STU:OS1
87GF Score
Otsuka Holdings Co Ltd STU:OS1
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Otsuka Holdings Co Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of €445 Mil mean?
Otsuka Holdings Co (STU:OS1) has a Common Stock of €445 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Otsuka Holdings Co and its competitors.
Is Otsuka Holdings Co's Common Stock too high?
Otsuka Holdings Co's current Common Stock is €445 Mil. Overall, Otsuka Holdings Co has a GF Score™ of 87/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Otsuka Holdings Co's Common Stock compare to LLY and JNJ?
Otsuka Holdings Co's Common Stock of €445 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Otsuka Holdings Co and its competitors. Otsuka Holdings Co's current Common Stock is €445 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Otsuka Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Otsuka Holdings Co (STU:OS1) is currently considered Significantly Overvalued. The stock's GF Value™ is €44.74, compared to a current price of €60.50 — trading 35.2% above its estimated fair value. The current Common Stock is €445 Mil. Otsuka Holdings Co's overall GF Score™ is 87/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Otsuka Holdings Co (STU:OS1), the current Common Stock is €445 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Otsuka Holdings Co (STU:OS1) Overvalued in 2026?

Based on GuruFocus' analysis, Otsuka Holdings Co stock appears to be overvalued. The current stock price of €60.50 is trading 35.2% above its estimated GF Value™ of €44.74. GuruFocus considers Otsuka Holdings Co to be Significantly Overvalued.

Key valuation signals for STU:OS1:

  • Common Stock: €445 Mil
  • GF Value™: €44.74 vs. price of €60.50 (35.2% above fair value)
  • GF Score™: 87/100 with 6 warning signs

No single metric tells the full story. See the STU:OS1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Otsuka Holdings Co Business Description

Address 2-16-4 Konan, Shinagawa Grand Central Tower, Minato-ku, Tokyo, JPN, 108-8241
Otsuka Holdings Co Ltd is a Japan-based company that operates in pharmaceuticals, nutraceuticals, and consumer products. It operates through four reportable segments: Medical-related Business, Nutraceutical-related Business, Consumer-related Business, and Other Business. The Medical Business manufactures and sells therapeutic drugs and infusions, the Nutraceutical Business produces functional foods, beverages, and nutritional supplements, the Consumer Business offers mineral water, beverages, and foods, while the Other Business provides storage services and manufactures chemicals and analytical equipment. It generates the majority of its revenue from the medical-related business segment.
87GF Score

Get the complete analysis for STU:OS1

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€60.50
Price
€44.74
GF Value